223
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Investigation of the Correlation Between the Polymorphism/Expression Level of RANTES and Its Receptor CCR5 Gene Promoter and Type 2 Diabetes Mellitus

ORCID Icon, , , , ORCID Icon &
Pages 213-223 | Received 18 Nov 2022, Accepted 31 Dec 2022, Published online: 24 Jan 2023

References

  • Esquivel Zuniga R, DeBoer MD. Prediabetes in adolescents: prevalence, management and diabetes prevention strategies. Diabetes Metab Syndr Obes. 2021;14:4609–4619. doi:10.2147/DMSO.S284401
  • Saeedi P, Salpea P, Karuranga S, et al. Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the international diabetes federation diabetes atlas. Diabetes Res Clin Pract. 2020;162:108086. doi:10.1016/j.diabres.2020.108086
  • Williams R, Karuranga S, Malanda B, et al. Global and regional estimates and projections of diabetes-related health expenditure: results from the international diabetes federation diabetes atlas. Diabetes Res Clin Pract. 2020;162:108072. doi:10.1016/j.diabres.2020.108072
  • Keshavarzi F, Golsheh S. IRS1- rs10498210 G/A and CCR5-59029 A/G polymorphisms in patients with type 2 diabetes in Kurdistan. Mol Genet Genomic Med. 2019;7(5):e631. doi:10.1002/mgg3.631
  • Fernández-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2008;19(1):10–16. doi:10.1016/j.tem.2007.10.004
  • O’Brien PD, Hinder LM, Parlee SD, et al. Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice. Diabetes Obes Metab. 2017;19(10):1468–1472. doi:10.1111/dom.12950
  • Zhang Z, Zhang X, Dong J, et al. Association of chemokine ligand 5/chemokine receptor 5 gene promoter polymorphisms with diabetic microvascular complications: a meta-analysis. J Diabetes Investig. 2016;7(2):212–218. doi:10.1111/jdi.12397
  • Zhu J, Wilding JPH. The 1α,25(OH)2D3 analogs ZK159222 and ZK191784 show anti-inflammatory properties in macrophage-induced preadipocytes via modulating the NF-κB and MAPK signaling. Diabetes Metab Syndr Obes. 2020;13:1715–1724. doi:10.2147/DMSO.S245080
  • Jamali Z, Nazari M, Khoramdelazad H, et al. Expression of CC chemokines CCL2, CCL5, and CCL11 is associated with duration of disease and complications in type-1 diabetes: a study on Iranian diabetic patients. Clin Lab. 2013;59(9–10):993–1001. doi:10.7754/Clin.Lab.2012.120810
  • Chou SY, Ajoy R, Changou CA, Hsieh YT, Wang YK, Hoffer B. CCL5/RANTES contributes to hypothalamic insulin signaling for systemic insulin responsiveness through CCR5. Sci Rep. 2016;6:37659. doi:10.1038/srep37659
  • Inayat H, Azim MK, Baloch AA. Analysis of inflammatory gene expression profile of peripheral blood leukocytes in type 2 diabetes. Immunol Invest. 2019;48(6):618–631. doi:10.1080/08820139.2019.1586917
  • Kochetova OV, Avzaletdinova DS, Morugova TV, Mustafina OE. Chemokine gene polymorphisms association with increased risk of type 2 diabetes mellitus in Tatar ethnic group, Russia. Mol Biol Rep. 2019;46(1):887–896. doi:10.1007/s11033-018-4544-6
  • Mohamed HG, Idris SB, Ahmed MF, et al. Influence of type 2 diabetes on local production of inflammatory molecules in adults with and without chronic periodontitis: a cross-sectional study. BMC Oral Health. 2015;15:86. doi:10.1186/s12903-015-0073-z
  • Lohmann T, Laue S, Nietzschmann U, et al. Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes. Diabetes. 2002;51(8):2474–2480. doi:10.2337/diabetes.51.8.2474
  • Dworacka M, Krzyżagórska E, Iskakova S, Bekmukhambetov Y, Urazayev O, Dworacki G. Increased circulating RANTES in type 2 diabetes. Eur Cytokine Netw. 2014;25(3):46–51. doi:10.1684/ecn.2014.0355
  • Tokarz A, Konkolewska M, Kuśnierz-Cabala B, et al. Retinopathy severity correlates with RANTES concentrations and CCR 5-positive microvesicles in diabetes. Folia Med Cracov. 2019;59(3):95–112. doi:10.24425/fmc.2019.131139
  • Longo PL, Artese HP, Rabelo MS, et al. Serum levels of inflammatory markers in type 2 diabetes patients with chronic periodontitis. J Appl Oral Sci. 2014;22(2):103–108. doi:10.1590/1678-775720130540
  • Pfleger C, Kaas A, Hansen L, et al; Hvidøre Study Group On Childhood Diabetes. Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes. Clin Immunol. 2008;128(1):57–65. doi:10.1016/j.clim.2008.03.458
  • Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106(16):2067–2072. doi:10.1161/01.CIR.0000034509.14906.AE
  • Carvalho-Pinto C, García MI, Gómez L, et al. Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. Eur J Immunol. 2004;34(2):548–557. doi:10.1002/eji.200324285
  • Boon J, Hoy AJ, Stark R, et al. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes. 2013;62(2):401–410. doi:10.2337/db12-0686
  • Hui N, Barter PJ, Ong KL, Rye KA. Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL. Clin Sci. 2019;133(21):2221–2235. doi:10.1042/CS20190873
  • Jonas K, Magoń W, Podolec P, Kopeć G. Triglyceride-to-high-density lipoprotein cholesterol ratio and systemic inflammation in patients with idiopathic pulmonary arterial hypertension. Med Sci Monit. 2019;25:746–753. doi:10.12659/MSM.912766
  • Sieg SF, Bazdar DA, Zidar D, Freeman M, Lederman MM, Funderburg NT. Highly oxidized low-density lipoprotein mediates activation of monocytes but does not confer interleukin-1β secretion nor interleukin-15 transpresentation function. Immunology. 2020;159(2):221–230. doi:10.1111/imm.13142
  • Li Q, Wang D, Wang Y, Xu Q. Simvastatin down regulates mRNA expression of RANTES and CCR5 in posttransplant renal recipients with hyperlipidemia. Transplant Proc. 2006;38(9):2899–2904. doi:10.1016/j.transproceed.2006.08.136
  • Hyde CL, Macinnes A, Sanders FA, et al. Genetic association of the CCR5 region with lipid levels in at-risk cardiovascular patients. Circ Cardiovasc Genet. 2010;3(2):162–168. doi:10.1161/CIRCGENETICS.109.897793
  • Słomiński B, Ławrynowicz U, Ryba-Stanisławowska M, Skrzypkowska M, Myśliwska J, Myśliwiec M. CCR5-Δ32 polymorphism is a genetic risk factor associated with dyslipidemia in patients with type 1 diabetes. Cytokine. 2019;114:81–85. doi:10.1016/j.cyto.2018.11.005
  • Cipriani S, Francisci D, Mencarelli A, et al. Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. Circulation. 2013;127(21):2114–2124. doi:10.1161/CIRCULATIONAHA.113.001278
  • Wu Y, Liu F, Zhang X, Shu L. Insulin modulates cytokines expression in human periodontal ligament cells. Arch Oral Biol. 2014;59(12):1301–1306. doi:10.1016/j.archoralbio.2014.07.002
  • Ghanim H, Korzeniewski K, Sia CL, et al. Suppressive effect of insulin infusion on chemokines and chemokine receptors. Diabetes Care. 2010;33(5):1103–1108. doi:10.2337/dc09-2193
  • Yang B, Houlberg K, Millward A, Demaine A. Polymorphisms of chemokine and chemokine receptor genes in type 1 diabetes mellitus and its complications. Cytokine. 2004;26(3):114–121. doi:10.1016/j.cyto.2004.01.005
  • Zhernakova A, Alizadeh BZ, Eerligh P, et al. Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes. Genes Immun. 2006;7(7):544–549. doi:10.1038/sj.gene.6364326
  • Herder C, Illig T, Baumert J, et al. RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Eur J Endocrinol. 2008;158(5):R1–R5. doi:10.1530/EJE-07-0686
  • Yadav AK, Kumar V, Dutta P, Bhansali A, Jha V. Variations in CCR5, but not HFE, ELMO1, or SLC12A3, are associated with susceptibility to kidney disease in north Indian individuals with type 2 diabetes. J Diabetes. 2014;6(6):547–555. doi:10.1111/1753-0407.12128
  • Shieh B, Liau YE, Hsieh PS, Yan YP, Wang ST, Li C. Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4. Int Immunol. 2000;12(9):1311–1318. doi:10.1093/intimm/12.9.1311
  • Buraczynska M, Zukowski P, Wacinski P, Berger-Smyka B, Dragan M, Mozul S. Chemotactic cytokine receptor 5 gene polymorphism: relevance to microvascular complications in type 2 diabetes. Cytokine. 2012;58(2):213–217. doi:10.1016/j.cyto.2012.01.007